Thanks for your comment P K Verma, Agree with your views, organisations need to focus on the methodology to ensure all channels should work seamlessly. While average effective rating is indicator, the bigger challenge is how do we add value and delight the Physicians and other stake-holders.

Thanks Velmurugan Sivarajan for your comment, I glad you liked the presentation and find research insightful. Digital transformation is about delighting the customers rather than marketing to the target group. It's about how all channels including Reps work seamlessly to add value to patients and other stakeholders. There are now good amount of well documented evidence e.g. Evidence Based Multichannel revised edition 2018 by Across Health. Also please refers to Samish Menon's webinar (Available on Credoweb) that provide relative effectiveness across channels, trust you may find these quite practical and useful. Undoubtedly, Reps are most preferred and highly effective and will always remain the question is what role they will play. Thanks again for your comments.

thanks sir for the response. I agree customer delight is an important objective for every marketing action,, the messages on social media that you presented were disturbing, hence the question on impact.

Great questions @ Velmurugan Sivarajan - such questions are necessary to broaden our understanding - thank you VS and Deep for the reply.

Thanks Mangalesh for your comment and feedback.

Thanks Bhaskar for your comment, I am happy you liked and find it relevant and useful, yes! I am concerned about Bobs, every-time I read Physicians frustrated / angry tweets, the real challenge is repurposing Customer Facing People job definition and re-skilling or up-skilling if they are promising. Thanks again for the feedback.

Thanks Prof Hattangadi for you inspiration and encouraging comment Sir.

Thanks Amlesh, happy you liked the topic and find it insightful. Thanks for the feedback, truly appreciate

Thanks Rajesh, I am glad you liked the presentation and find it enriching.

Dear Ravindra the current situation indicates, that the pharmaceutical industry's business-model of "simply selling pills" cannot sustain in the future. It is far too simple, calling a physician "customer" trying to "sell a drug" to this so-called customer. The future of this industry will lie in adding true value to care, helping physicians to improve their patient's outcome and health. Necessary knowledge and expertise, money to be invested, and many highly skilled people are available. Only the objective must be re-worded. It must no longer sound like "sales" and "market-share." This industry's activities in the future will be centered around better patient-outcome. The learning curve will be steep and not many will successfully climb this ladder. By the way: means to achieve better patient-outcome are manifold. Many, not all, will be from a "digital" nature.

Thanks Hanno for your comment and valuable inputs including "to achieve better patient-outcome are manifold. Many, not all, will be from a "digital" nature".

Thanks Amit, completely agree, thanks for your comment.